Distinct Mechanisms of Biotic and Chemical Elicitors Enable Additive Elicitation of the Anticancer Phytoalexin Glyceollin I

Total Page:16

File Type:pdf, Size:1020Kb

Distinct Mechanisms of Biotic and Chemical Elicitors Enable Additive Elicitation of the Anticancer Phytoalexin Glyceollin I molecules Article Distinct Mechanisms of Biotic and Chemical Elicitors Enable Additive Elicitation of the Anticancer Phytoalexin Glyceollin I Kelli Farrell 1,†, Md Asraful Jahan 2,† and Nik Kovinich 2,* 1 Department of Biology, West Virginia University, Morgantown, WV 26506, USA; [email protected] 2 Division of Plant and Soil Sciences, West Virginia University, Morgantown, WV 26506, USA; [email protected] * Correspondence: [email protected]; Tel.: +1-304-293-9240 † These Authors contributed equally to this article. Received: 16 June 2017; Accepted: 25 July 2017; Published: 27 July 2017 Abstract: Phytoalexins are metabolites biosynthesized in plants in response to pathogen, environmental, and chemical stresses that often have potent bioactivities, rendering them promising for use as therapeutics or scaffolds for pharmaceutical development. Glyceollin I is an isoflavonoid phytoalexin from soybean that exhibits potent anticancer activities and is not economical to synthesize. Here, we tested a range of source tissues from soybean, in addition to chemical and biotic elicitors, to understand how to enhance the bioproduction of glyceollin I. Combining the inorganic chemical silver nitrate (AgNO3) with the wall glucan elicitor (WGE) from the soybean pathogen Phytophthora sojae had an additive effect on the elicitation of soybean seeds, resulting in a yield of up to 745.1 µg gt−1 glyceollin I. The additive elicitation suggested that the biotic and chemical elicitors acted largely by separate mechanisms. WGE caused a major accumulation of phytoalexin gene transcripts, whereas 00 AgNO3 inhibited and enhanced the degradation of glyceollin I and 6 -O-malonyldaidzin, respectively. Keywords: bioproduction; phytoalexin; isoflavonoid; glyceollin; soybean [Glycine max (L.) Merr.] 1. Introduction Plants, like other organisms, have metabolic pathways that remain silent until activated by stresses. Phytoalexins are defense metabolites biosynthesized in response to pathogens, but which for unknown reasons also accumulate in response to specific environmental stresses and inorganic chemicals, such as heavy metals [1–3]. Much of what is known about phytoalexin elicitation mechanisms comes from studies of the glyceollins in soybean, camalexins in Arabidopsis, diterpenoids and flavonoids in rice, stilbenes in grapevine, alkaloids in California poppy, and the 3-deoxyanthocyanidins, terpenoids, and phytodienoic acids in maize. However, very few studies have attempted to distinguish the elicitation mechanisms of biotic and chemical elicitors. Biotic elicitation begins when a microbial derived pathogen-associated molecular pattern (PAMP) or effector binds to a pattern recognition receptor at the plasma membrane of the plant cell. Mitogen-activated protein kinase (MAPK) or phospholipase signaling ultimately results in the expression of transcription factors (TFs) that directly activate the transcription of phytoalexin biosynthesis genes. MYB-, bHLH-, or WRKY-type TFs directly activate some or all of the phytoalexin biosynthesis genes in cotton, sorghum, rice, Arabidopsis, and grapevine [4–6]. In soybean, no phytoalexin TF has been identified, but transcription of glyceollin biosynthesis genes was coordinately induced in response to the pathogen Phytophthora sojae [7,8]. Heavy metals, such as silver nitrate (AgNO3), have elicited chemically diverse phytoalexins in many plant species. The molecular target(s) of these heavy metals remain(s) unknown. AgNO3 was Molecules 2017, 22, 1261; doi:10.3390/molecules22081261 www.mdpi.com/journal/molecules Molecules 2017, 22, 1261 2 of 13 Molecules 2017, 22, 1261 2 of 12 shown to inhibit developmental processes triggered by exogenous ethylene treatment, and thus has shown to inhibit developmental processes triggered by exogenous ethylene treatment, and thus has been considered a potent inhibitor of ethylene perception [9]. Some evidence has suggested that AgNO3 been considered a potent inhibitor of ethylene perception [9]. Some evidence has suggested that AgNO3 and pathogens elicit phytoalexins primarily by different mechanisms. The P. sojae-resistant soybean and pathogens elicit phytoalexins primarily by different mechanisms. The P. sojae-resistant soybean variety Harosoy 63 elicited glyceollins rapidly in response to race 1 P. sojae, but the susceptible variety variety Harosoy 63 elicited glyceollins rapidly in response to race 1 P. sojae, but the susceptible variety Harosoy did not, whereas both varieties responded similarly to AgNO3 [10]. Feeding AgNO3-elicited Harosoy did not, whereas both varieties responded similarly to AgNO3 [10]. Feeding AgNO3-elicited soybean cotyledons the radiolabeled intermediate phenylalanine did not result in radiolabeled soybean cotyledons the radiolabeled intermediate phenylalanine did not result in radiolabeled glyceollins, but AgNO3 treatment reduced the degradation of radiolabeled glyceollins [11]. glyceollins, but AgNO3 treatment reduced the degradation of radiolabeled glyceollins [11]. GlyceollinsGlyceollins are are thethe major major phytoalexins phytoalexins of the of thesoyb soybean.ean. They belong They to belong the pterocarpan to the pterocarpan subclass subclassof isoflavonoids, of isoflavonoids, which possesses which great possesses potential great as scaffolds potential for pharmaceutical as scaffolds fordevelopment pharmaceutical [12]. developmentGlyceollins [are12]. biosynthesized Glyceollins are from biosynthesized the isoflavonoid from thedaidzein, isoflavonoid which can daidzein, result whichfrom de can novo result frombiosynthesis de novo biosynthesis beginning at beginningphenylalanine, at phenylalanine, or possibly from or possiblythe hydrolysis from of the preformed hydrolysis isoflavonoid- of preformed isoflavonoid-glycosideglycoside conjugates conjugates(Figure 1). (FigureGlyceollins1). Glyceollinshave broad-spectrum have broad-spectrum antiproliferative antiproliferative or antitumor or antitumoractivities activities against human against lung, human breast, lung, prostate, breast, prostate,ovary, skin, ovary, and skin,kidney and cancers. kidney Glyceollin cancers. Glyceollin I is the I ismost the potent, most potent, and directly and directlyantagonizes antagonizes human estrogen human receptor estrogen α (ER receptorα) andα ER(ERβ [13].α)and Glyceollin ERβ [ 13I ]. Glyceollinalso exhibits I also a rare exhibits ER-independent a rare ER-independent mode-of-action via mode-of-action a mechanism that via is anot mechanism yet fully understood that is not [14]. yet fullyIn understoodlight of the therapeutic [14]. In light potential of the therapeutic of glyceollin potential I, studies of have glyceollin attempted I, studies to produce have attemptedlarge-scale to produce(gram)large-scale amounts by (gram) chemical amounts synthesis by or chemical by the elic synthesisitation of orsoybean by the [15,16]. elicitation However, of soybean the yield [15 by,16 ]. However,chemical the synthesis yield by was chemical up to 12%, synthesis and required was up a high to 12%,ly concerted and required effort of a highlyspecialists concerted six months effort to of specialistscomplete, six rendering months toit complete,uneconomical rendering for commercial it uneconomical production for commercial[15]. Here, we production aimed to [identify15]. Here, wewhich aimed soybean to identify tissues which and soybean treatments tissues provide and optimal treatments glyceollin provide I bioproduction optimal glyceollin in vitro. I bioproduction Our study in vitroprovides. Our novel study insight provides into how novel biotic insight and chemical into how elicitation biotic and pathways chemical are elicitation distinct, and pathways how this are can be exploited to enhance the bioproduction of glyceollin I. distinct, and how this can be exploited to enhance the bioproduction of glyceollin I. Figure 1. Glyceollin I biosynthetic pathway. In addition to de novo biosynthesis, the constitutively Figure 1. Glyceollin I biosynthetic pathway. In addition to de novo biosynthesis, the constitutively 00 accumulatingaccumulating isoflavone isoflavone conjugate conjugate 66″--OO-malonyldaidzin-malonyldaidzin may may be be hydrolyzed hydrolyzed to to provide provide daidzein daidzein intermediatesintermediates for for glyceollin glyceollin I biosynthesis. biosynthesis. CHS, CHS, chalcone chalcone synthase; synthase; CHR, CHR,chalcone chalcone reductase; reductase; CHI, 0 0 CHI,chalcone chalcone isomerase; isomerase; IFS, isoflavo IFS, isoflavonene synthase; synthase; I2’H, isoflavone I2 H, isoflavone2′-hydroxylase; 2 -hydroxylase; G4DT, glycinol G4DT, 4- glycinoldimethylallyl 4-dimethylallyl transferase; transferase; G2DT, glycinol G2DT, 2-dimethylallyl glycinol 2-dimethylallyl transferase; transferase;GLS, glyceollin GLS, synthase; glyceollin 00 synthase;UF7GT UF7GT(UGT88E3) (UGT88E3) UDP-glucose:isoflavone-7- UDP-glucose:isoflavone-7-O-glucosyltransferase;O-glucosyltransferase; I6″OMT (GmMT7) I6 OMT isoflavone- (GmMT7) 00 isoflavone-7-7-O-glucoside-6O-glucoside-6″-O-methyltransferase.-O-methyltransferase. Molecules 2017, 22, 1261 3 of 13 Molecules 2017, 22, 1261 3 of 12 2.2. Results and DiscussionDiscussion 2.1.2.1. Imbibing SoybeanSoybean SeedsSeeds AreAre thethe MostMost AbundantAbundant SourceSource ofof GlyceollinGlyceollin II PriorPrior studiesstudies havehave foundfound thatthat glyceollinsglyceollins werewere readilyreadily elicitedelicited upup toto thethe first-true-leaffirst-true-leaf stagestage ofof development,development, whenwhen they they were were essential essential for for
Recommended publications
  • Biologically Active Molecules from Soybeans
    10 Biologically Active Molecules from Soybeans Michio Kurosu Department of Pharmaceutical Sciences, University of Tennessee Health Science Center USA 1. Introduction Soybeans (Glycine max [L.] Merr.) contain an impressive array of biologically active components. People have been eating soybeans for almost 5,000 years. Unlike most plant foods, soybeans are high in protein. Researchers are interested in both the nutritional value and the potential health benefits of soybeans. Research of the health effects of soyfoods and soybean constituents has been received significant attention to support the health improvements or health risks observed clinically or in vitro experiments. This research includes a wide range of areas, such as cancer, coronary heart disease (cardiovascular disease), osteoporosis, cognitive function (memory related), menopausal symptoms, renal function, and many others. This chapter provides up-to-date coverage on biologically active and related organic molecules isolated from soy and soy products. Their biological activities are briefly summarized. Molecules discussed in this chapter are as follows: isoflavones, phytic acid, soy lipids, soy phytoalexins, soyasaponins, lectins, hemagglutinin, soy toxins, and vitamins. 2. Health benefit of soy or soy products Soy products have been considered as great source of protein for many decades. Japanese, in particular, eat a soy-based diet. Japanese monks eat soy products as their main protein source. They are known to live longer and have lower rates of chronic diseases. Because soybeans contain practically no starch, soybeans are an important part of a diabetic diet. Soybeans are 1) rich in protein (vide supra), calcium, and vitamins, and 2) high in mono- saturated fatty acids. In addition, soybeans contain several biologically interesting phytochemicals as minor components, which scientists are interested in understanding their biological functions.
    [Show full text]
  • Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia Phymatum Σ54 During Symbiosis with Phaseolus Vulgaris
    Research Collection Journal Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Author(s): Lardi, Martina; Liu, Yilei; Giudice, Gaetano; Ahrens, Christian H.; Zamboni, Nicola; Pessi, Gabriella Publication Date: 2018-04 Permanent Link: https://doi.org/10.3929/ethz-b-000258158 Originally published in: International Journal of Molecular Sciences 19(4), http://doi.org/10.3390/ijms19041049 Rights / License: Creative Commons Attribution 4.0 International This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library International Journal of Molecular Sciences Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Martina Lardi 1, Yilei Liu 1, Gaetano Giudice 1, Christian H. Ahrens 2, Nicola Zamboni 3 and Gabriella Pessi 1,* ID 1 Department of Plant and Microbial Biology, University of Zurich, CH-8057 Zurich, Switzerland; [email protected] (M.L.); [email protected] (Y.L.); [email protected] (G.G.) 2 Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics & Swiss Institute of Bioinformatics (SIB), CH-8820 Wädenswil, Switzerland; [email protected] 3 Institute of Molecular Systems Biology, ETH Zurich, CH-8093 Zurich, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +41-44-6352904 Received: 28 February 2018; Accepted: 28 March 2018; Published: 1 April 2018 Abstract: RpoN (or σ54) is the key sigma factor for the regulation of transcription of nitrogen fixation genes in diazotrophic bacteria, which include α- and β-rhizobia.
    [Show full text]
  • The Pharmacologist 2 0 0 6 December
    Vol. 48 Number 4 The Pharmacologist 2 0 0 6 December 2006 YEAR IN REVIEW The Presidential Torch is passed from James E. Experimental Biology 2006 in San Francisco Barrett to Elaine Sanders-Bush ASPET Members attend the 15th World Congress in China Young Scientists at EB 2006 ASPET Awards Winners at EB 2006 Inside this Issue: ASPET Election Online EB ’07 Program Grid Neuropharmacology Division Mixer at SFN 2006 New England Chapter Meeting Summary SEPS Meeting Summary and Abstracts MAPS Meeting Summary and Abstracts Call for Late-Breaking Abstracts for EB‘07 A Publication of the American Society for 121 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 4, 2006 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The Editor PHARMACOLOGIST Suzie Thompson EDITORIAL ADVISORY BOARD Bryan F. Cox, Ph.D. News Ronald N. Hines, Ph.D. Terrence J. Monks, Ph.D. 2006 Year in Review page 123 COUNCIL . President Contributors for 2006 . page 124 Elaine Sanders-Bush, Ph.D. Election 2007 . President-Elect page 126 Kenneth P. Minneman, Ph.D. EB 2007 Program Grid . page 130 Past President James E. Barrett, Ph.D. Features Secretary/Treasurer Lynn Wecker, Ph.D. Secretary/Treasurer-Elect Journals . Annette E. Fleckenstein, Ph.D. page 132 Past Secretary/Treasurer Public Affairs & Government Relations . page 134 Patricia K. Sonsalla, Ph.D. Division News Councilors Bryan F. Cox, Ph.D. Division for Neuropharmacology . page 136 Ronald N. Hines, Ph.D. Centennial Update . Terrence J. Monks, Ph.D. page 137 Chair, Board of Publications Trustees Members in the News .
    [Show full text]
  • Phytoalexins: Current Progress and Future Prospects
    Phytoalexins: Current Progress and Future Prospects Edited by Philippe Jeandet Printed Edition of the Special Issue Published in Molecules www.mdpi.com/journal/molecules Philippe Jeandet (Ed.) Phytoalexins: Current Progress and Future Prospects This book is a reprint of the special issue that appeared in the online open access journal Molecules (ISSN 1420-3049) in 2014 (available at: http://www.mdpi.com/journal/molecules/special_issues/phytoalexins-progress). Guest Editor Philippe Jeandet Laboratory of Stress, Defenses and Plant Reproduction U.R.V.V.C., UPRES EA 4707, Faculty of Sciences, University of Reims, PO Box. 1039, 51687 Reims cedex 02, France Editorial Office MDPI AG Klybeckstrasse 64 Basel, Switzerland Publisher Shu-Kun Lin Managing Editor Ran Dang 1. Edition 2015 MDPI • Basel • Beijing ISBN 978-3-03842-059-0 © 2015 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons Attribution 3.0 license (http://creativecommons.org/licenses/by/3.0/), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. However, the dissemination and distribution of copies of this book as a whole is restricted to MDPI, Basel, Switzerland. III Table of Contents About the Editor ............................................................................................................... VII List of
    [Show full text]
  • ABSTRACT Title of Document: BIOLOGICAL
    ABSTRACT Title of Document: BIOLOGICAL EFFICACY, MECHANISMS OF ACTIONS OF SOY-DERIVED PHYTOALEXIN GLYCEOLLINS IN PREVENTION OF CHRONIC DISEASES Haiqiu Huang, Doctor of Philosophy, 2014 Directed By: Professor Liangli (Lucy) Yu Department of Nutrition and Food Science Cardiovascular disease (CVD) is the leading cause of deaths worldwide. Prostate cancer is the most prevalent cancer in U.S. male population. Diet-induced hypercholesterolemia and chronic inflammation promote the development of both CVD and prostate cancer. Glyceollins are a group of soy phytoalexins possessing a variety of biological activities. This research project focused on characterizing glyceollins’ bioactivities in alleviating cholesterol dysregulation, prevention of prostate cancer, and regulating gut microbiome. The first part of the project aimed to evaluate glyceollins’ cholesterol- lowering effect in-vivo. Male golden Syrian hamsters were fed high-fat diet with or without glyceollins supplementation for 28 days. Glyceollins supplementation led to a significant reduction of plasma VLDL, hepatic cholesterol esters and total lipid content. Consistent with changes in circulating cholesterol, glyceollins supplementation also altered expression of the genes related to cholesterol metabolism in the liver. The second part of the study aimed to evaluate glyceollins’ effect in reducing prostate cancer tumor growth in a xenograft model. An initial delayed appearance of tumor was observed in a PC-3 xenograft model. However, no difference in tumor sizes was observed in a LNCaP xenograft model. Extrapolation analysis of tumor measurements indicated that no difference in sizes was expected for both PC-3 and LNCaP tumors. Glyceollins had no effect on the androgen responsive pathway, its proliferation, cell cycle, or on angiogenesis genes in tumor and xenobiotic metabolism, cholesterol transport, and inflammatory cytokine genes in liver.
    [Show full text]
  • Appendix 1 – Protocol for Preventing Or Reversing Chronic Disease The
    Appendix 1 – Protocol for Preventing or Reversing Chronic Disease The first author has developed a protocol over the past decade for preventing or reversing chronic disease based on the following systemic medical principle: “at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective”[1]. The protocol methodology refines the age-old principles of both reducing harm in addition to providing treatment, and allows better identification of factors that contribute to the disease process (so that they may be eliminated if possible). These contributing factors are expansive and may include a combination of Lifestyle choices (diet, exercise, smoking), iatrogenic and biotoxin exposures, environmental/occupational exposures, and psychosocial stressors. This strategy exploits the existing literature to identify patterns of biologic response using biomarkers from various modalities of diagnostic testing to capture a much broader list of potential contributing factors. Existing inflammatory bowel diseases (IBD) Biomarker Identification to Remove Contributing Factors and Implement Treatment The initial protocol steps are diagnostic. The main output of these diagnostics will be identification of the biomarker levels and symptoms that reflect abnormalities, and the directions of change required to eliminate these abnormalities. In the present study, hundreds of general and specific biomarkers and symptoms were identified from the core IBD literature. The highest frequency (based on numbers of record appearances) biomarkers and symptoms were extracted, and are listed in Table 1 (highest frequency items first, reading down each column before proceeding to the next column). They are not necessarily consensus biomarkers. They are biomarkers whose values were altered by a treatment or contributing factor, and reported in the core IBD literature.
    [Show full text]
  • Gmmyb176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 6-28-2017 12:00 AM GmMYB176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean Arun Kumaran Anguraj Vadivel The University of Western Ontario Supervisor Dr. Sangeeta Dhaubhadel The University of Western Ontario Joint Supervisor Dr. Mark Bernards The University of Western Ontario Graduate Program in Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Arun Kumaran Anguraj Vadivel 2017 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Molecular Biology Commons, and the Plant Biology Commons Recommended Citation Anguraj Vadivel, Arun Kumaran, "GmMYB176 Interactome and Regulation of Isoflavonoid Biosynthesis in Soybean" (2017). Electronic Thesis and Dissertation Repository. 4639. https://ir.lib.uwo.ca/etd/4639 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. i Abstract MYB transcription factors are one of the largest transcription factor families characterized in plants. They are classified into four types: R1 MYB, R2R3 MYB, R3 MYB and R4 MYB. GmMYB176 is an R1MYB transcription factor that regulates Chalcone synthase (CHS8) gene expression and isoflavonoid biosynthesis in soybean. Silencing of GmMYB176 suppressed the expression of the GmCHS8 gene and reduced the accumulation of isoflavonoids in soybean hairy roots. However, overexpression of GmMYB176 does not alter either GmCHS8 gene expression or isoflavonoid levels suggesting that GmMYB176 alone is not sufficient for GmCHS8 gene regulation.
    [Show full text]
  • The Science of Flavonoids the Science of Flavonoids
    The Science of Flavonoids The Science of Flavonoids Edited by Erich Grotewold The Ohio State University Columbus, Ohio, USA Erich Grotewold Department of Cellular and Molecular Biology The Ohio State University Columbus, Ohio 43210 USA [email protected] The background of the cover corresponds to the accumulation of flavonols in the plasmodesmata of Arabidopsis root cells, as visualized with DBPA (provided by Dr. Wendy Peer). The structure corresponds to a model of the Arabidopsis F3 'H enzyme (provided by Dr. Brenda Winkel). The chemical structure corresponds to dihydrokaempferol. Library of Congress Control Number: 2005934296 ISBN-10: 0-387-28821-X ISBN-13: 978-0387-28821-5 ᭧2006 Springer ScienceϩBusiness Media, Inc. All rights reserved. This work may not be translated or copied in whole or in part without the written permission of the publisher (Springer ScienceϩBusiness Media, Inc., 233 Spring Street, New York, NY 10013, USA), except for brief excerpts in connection with reviews or scholarly analysis. Use in connection with any form of information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed is forbidden. The use in this publication of trade names, trademarks, service marks and similar terms, even if they are not identified as such, is not to be taken as an expression of opinion as to whether or not they are subject to proprietary rights. Printed in the United States of America (BS/DH) 987654321 springeronline.com PREFACE There is no doubt that among the large number of natural products of plant origin, debatably called secondary metabolites because their importance to the eco- physiology of the organisms that accumulate them was not initially recognized, flavonoids play a central role.
    [Show full text]
  • Isoflavonoid Biosynthesis 21321.Pdf
    Isoflavonoid Biosynthesis https://www.kegg.jp/kegg-bin/highlight_pathway?scale=1.0&map=map00943&keyword=flavonoids Isoflavonoids are biologically active compounds, such as phytoestrogens, produced by pea family plants. While flavonoids (in the narrow sense) have the 2- phenylchromen-4-one backbone, isoflavonoids have the 3-phenylchromen-4-one backbone with no hydroxyl group substitution at position 2. Isoflavonoids are derived from the flavonoid biosynthesis pathway via liquiritigenin or naringenin. (Flavonoid Biosynthesis) -> [1,2] 1) Liquiritigenin -> [1,2,3] 1) flavone synthesis I & II -> 7,4’Dihydroxyflavone OR 2) flavonoid 6-hydroxylase -> 6,7,4’-Trihydroxyflavanone -> 2- hydroxyisoflavone synthase -> 2,6,7,4’-tetrahydroxyisoflavanone -> 6- Hydroxydaidzein -> Glycitein -> isoflavone 7-O-glucosyltransferase -> Glycitein 7-O-glucoside -> isoflavone 7-O-glucoside-6’’-O-malonyltransferase -> Glycitein 7-O-glucoside-6”-O-malonate OR 3) 2-hydroxyisoflavanone synthase -> 2,7,4’Trihydroxyisoflavanone -> [1,2] 1) Feedback Loop 2,7,4’-trihydroxyisoflavanone 4’-O-methyltransferase / isoflavone 4’-O-methyltransferase -> 2,7-Dihydroxy-4’-methoxyisoflavanone -> 2- hydroxyisoflavanone dehydratase -> Formononetin OR 2) 2-hydroxyisoflavone dehydratase -> Daidzein -> [1,2,3,4,5] 1) isoflavone/4’-methoxyisoflavone 2’-hydroxylase -> 2’Hydroxydaidzein -> 2’Hydroxydaidzein reductase -> 2’-Hydroxydihydrodaidzein -> 3,9-Dihydroxypterocarpan -> 3,9-dihydroxypterocarpan 6a-monooxygenase -> 3,6,9- Trihydroxypterocarpan -> [1,2] 1) trihydroxypterocarpan dimethylallyltransferase
    [Show full text]
  • Molecular Pathways of Estrogen Receptor Action
    International Journal of Molecular Sciences Molecular Pathways of Estrogen Receptor Action Edited by Farzad Pakdel Printed Edition of the Special Issue Published in International Journal of Molecular Sciences www.mdpi.com/journal/ijms Molecular Pathways of Estrogen Receptor Action Molecular Pathways of Estrogen Receptor Action Special Issue Editor Farzad Pakdel MDPI • Basel • Beijing • Wuhan • Barcelona • Belgrade Special Issue Editor Farzad Pakdel University of Rennes France Editorial Office MDPI St. Alban-Anlage 66 Basel, Switzerland This is a reprint of articles from the Special Issue published online in the open access journal International Journal of Molecular Sciences (ISSN 1422-0067) from 2017 to 2018 (available at: https: //www.mdpi.com/journal/ijms/special issues/estrogen) For citation purposes, cite each article independently as indicated on the article page online and as indicated below: LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. Journal Name Year, Article Number, Page Range. ISBN 978-3-03897-296-9 (Pbk) ISBN 978-3-03897-297-6 (PDF) Articles in this volume are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. The book taken as a whole is c 2018 MDPI, Basel, Switzerland, distributed under the terms and conditions of the Creative Commons license CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/). Contents About the Special Issue Editor ...................................... vii Farzad Pakdel Molecular Pathways of Estrogen Receptor Action Reprinted from: Int.
    [Show full text]
  • Identification and Characterization of the Isoflavonoid-Specific Prenyltransferase Gene Family to Prevent Stem and Root Rot in Soybean
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 9-30-2016 12:00 AM Identification and Characterization of the Isoflavonoid-Specific Prenyltransferase Gene Family to Prevent Stem and Root Rot in Soybean Arjun Sukumaran The University of Western Ontario Supervisor Dr. Sangeeta Dhaubhadel The University of Western Ontario Graduate Program in Biology A thesis submitted in partial fulfillment of the equirr ements for the degree in Master of Science © Arjun Sukumaran 2016 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Biology Commons, Genetics and Genomics Commons, Plant Biology Commons, and the Plant Pathology Commons Recommended Citation Sukumaran, Arjun, "Identification and Characterization of the Isoflavonoid-Specific Prenyltransferase Gene Family to Prevent Stem and Root Rot in Soybean" (2016). Electronic Thesis and Dissertation Repository. 4130. https://ir.lib.uwo.ca/etd/4130 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. i Abstract Soybean is one of the most predominantly grown legumes worldwide, however, one deterrent to maximizing its yield is the pathogen, Phytophthora sojae, which causes stem and root rot disease. Many strategies have been implemented to combat this pathogen such as use of pesticides and certain agricultural practices. However, these have been largely ineffective in completely preventing P. sojae infection. An alternative strategy would be to improve the innate resistance of soybean by promoting increased glyceollin production. Glyceollins are soybean-specific antimicrobial agents which are derived from the isoflavonoid branch of the general phenylpropanoid pathway.
    [Show full text]
  • Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Fungicide
    Dr. Duke's Phytochemical and Ethnobotanical Databases List of Chemicals for Fungicide Chemical Dosage (+)-3-HYDROXY-9-METHOXYPTEROCARPAN IC26-78=100 uM (+)-VESTITONE -- (-)-3-HYDROXY-9-METHOXYPTEROCARPAN IC31-69=100 uM (-)-ACANTHOCARPAN ED50=<50-100 (-)-APIOCARPIN ED50=<50 (-)-CANESCACARPIN ED50=<50 (-)-CLANDESTACARPIN ED50=<50 (-)-CRISTACARPIN ED50=<50 (-)-DEMETHYLMEDICARPIN EC50=50-100 (-)-DOLICHIN-A ED50=>100 (-)-DOLICHIN-B ED50=>100 (-)-EPIGALLOCATECHIN-GALLATE -- (-)-GLYCEOCARPIN ED50=50-100 (-)-GLYCEOFURAN ED50=>100 (-)-GLYCEOLLIN-I ED50=<50 (-)-GLYCEOLLIN-II ED50=<50 (-)-GLYCEOLLIN-III ED50=<50 (-)-GLYCEOLLIN-IV ED50=<50 (-)-GLYCINOL ED50=50->100 (-)-ISOSATIVAN -- (-)-JASMONIC-ACID -- (-)-MEDICARPIN ED50=<50 (-)-VESTITOL -- (-)-VESTITONE -- (Z)-1,3-BIS(4-HYDROXYPHENYL)-1,4-PENTADIENE -- -METHOXYBRASSITIN -- 1,2-DIHYDROXY-4-GLUCOSYLNAPTHALENE -- Chemical Dosage 1,2-DIMETHOXY-3,8-DIHYDROXYXANTHONE > miconazole 1,7-DIHYDROXY-4-METHOXYXANTHONE <miconazole 1,8-CINEOLE -- 1-TULIPOSIDE-A -- 1-TULIPOSIDE-B -- 13',II8-BIAPIGENIN -- 15-GLUCOPYRANOSYL-GLAUCORUBOLONE -- 2'-HYDROXYDAIDZEIN ED50=>100 2'-HYDROXYGENISTEIN ED50=50->100 2,3-DEHYDROKIEVITONE -- 2,6-DIMETHOXY-P-BENZOQUINONE -- 2,7-DIMETHOXY-5-ISOPROPYL-3-METHYL-8,1-NAPTHALENE-CARBOLACTONE -- 2-HYDROXY-5-ISOPROPYL-7-METHOXY-3-METHYL-8,1-NAPTHALENE-CARBOLACTONE -- 2-METHOXYPHASEOLLINISOFLAVON IC80-89=100uM 26-DESGLUCOAVENACOSIDE-A -- 26-DESGLUCOAVENACOSIDE-B -- 3'-FORMYL-2',4',6'-TRIHYDROXY-5'-METHYLDIHYDROCHALCONE -- 3'-FORMYL-2',4',6'-TRIHYDROXYDIHYDROCHALCONE -- 3,4-DIMETHOXYTOLUENE
    [Show full text]